Publications by authors named "Francesca Barei"

Claim this Profile
E
Effectiveness of Dupilumab and Tralokinumab in Treating Nummular Eczema.
Francesca Barei, Alessandra Chiei Gallo, Roberto Pinto, Martina Zussino, Angelo V Marzano

Int J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo, Caterina Foti, Ilaria Trave, Francesca Barei

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patch Testing Under Biologics: Six Cases From a Tertiary Centre.
Alessandra Chiei-Gallo, Francesca Barei, Angelo V Marzano, Silvia M Ferrucci

Contact Dermatitis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.
Francesca Barei, Paolo Calzari, Stefano Macchi, Simone Ribero, Michela Ortoncelli

Dermatitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of upadacitinib in patients with moderate-to-severe atopic dermatitis and prior inefficacy of T helper 2 biologics: a propensity score-matched study.
Francesca Barei, Alessandra Chiei-Gallo, Alessandra Narcisi, Ruggero Cascio Ingurgio, Piergiorgio Malagoli

Clin Exp Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study.
Francesca Barei, Stefano Macchi, Paolo Calzari, Simone Ribero, Michela Ortoncelli

Clin Exp Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis.
Gianluca Avallone, Andrea Bombelli, Luca Valtellini, Gianluca Tavoletti, Benedetta Galli, Francesca Barei

Clin Exp Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK Inhibitors in Atopic Dermatitis: Does Weight Matter? A Real-World, Nationwide Retrospective Study: IL-AD (Italian Landscape Atopic Dermatitis).
Mariateresa Rossi, Stefano Bighetti, Alessandra Narcisi, Antonio Costanzo, Matteo Bianco, Francesca Barei

Dermatol Ther (Heidelb)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center.
Alessandra Chiei Gallo, Gianluca Tavoletti, Davide Termini, Gianluca Avallone, Francesca Barei

Int J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study.
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, Michela Ortoncelli, Simone Ribero, Francesca Barei

Clin Exp Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study.
Luigi Gargiulo, Silvia M Ferrucci, Luciano Ibba, Ruggero Cascio Ingurgio, Angela Alfano, Francesca Barei

J Eur Acad Dermatol Venereol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study.
Luca Bettolini, Stefano Bighetti, Silvia Mariel Ferrucci, Angelo Valerio Marzano, Francesca Barei

Antibodies (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, Michela Ortoncelli, Simone Ribero, Francesca Barei

Int J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study.
Gianluca Avallone, Luca Valtellini, Gianluca Tavoletti, Luca Mastorino, Martina Maurelli, Francesca Barei

Dermatitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and drug survival of tralokinumab in patients with severe atopic dermatitis: an 18-month multicentre study.
Francesca Barei, Paolo Calzari, Elena Pezzolo, Maddalena Napolitano, Mariateresa Rossi

Clin Exp Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.
Giuseppe Lauletta, Luca Potestio, Cataldo Patruno, Silvia Mariel Ferrucci, Luisa Angileri, Francesca Barei

Dermatitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy.
Alessandra Chiei Gallo, Gianluca Tavoletti, Gianluca Avallone, Eleonora Bono, Francesca Barei

Contact Dermatitis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study.
Francesco Leo, Michela Ortoncelli, Ruggero Cascio Ingurgio, Benedetta Galli, Laura Grigolato, Francesca Barei

Am J Clin Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis).
Luca Potestio, Cataldo Patruno, Alessandra Narcisi, Antonio Costanzo, Luciano Ibba, Francesca Barei

Arch Dermatol Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study.
Alessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, Armando Pisapia, Angelo V Marzano

Int J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes.
Francesca Barei, Paolo Calzari, Elena Pezzolo, Maddalena Napolitano, Mariateresa Rossi

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year observational study on the ​long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitis.
Alessandra Chiei-Gallo, Francesca Barei, Paolo Calzari, Armando Pisapia, Angelo V Marzano

Clin Exp Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Luigi Gargiulo, Luciano Ibba, Angela Alfano, Piergiorgio Malagoli, Fabrizio Amoruso, Francesca Barei

J Dermatolog Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors.
Francesca Barei, Paolo Calzari, Luca Valtellini, Alessandra Chiei Gallo, Gabriele Perego

J Dermatolog Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special sites in atopic dermatitis: Effectiveness of dupilumab on the hands in a single-centre study on 485 patients.
Gabriele Perego, Italo Francesco Aromolo, Francesca Barei, Martina Zussino, Luca Valtellini

Australas J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis